Pure Global

"Simogine" Odosibe Cytosis II Fractional System - Taiwan Registration c9efae52dd03894e63c4beebafee4265

Access comprehensive regulatory information for "Simogine" Odosibe Cytosis II Fractional System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c9efae52dd03894e63c4beebafee4265 and manufactured by THERMOGENESIS CORP.. The authorized representative in Taiwan is QUALTECH CONSULTING CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
c9efae52dd03894e63c4beebafee4265
Registration Details
Taiwan FDA Registration: c9efae52dd03894e63c4beebafee4265
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Simogine" Odosibe Cytosis II Fractional System
TW: โ€œ่ฉฉ่Žซๅ‰ๅ…งโ€ ๅฅงๅคšๅธญ่ฒ่ก€็ƒ็ดฐ่ƒžๅˆ†้›ข็ณป็ตฑไบŒไปฃ
Risk Class 2

Registration Details

c9efae52dd03894e63c4beebafee4265

DHA05603618704

Company Information

United States

Product Details

This product is a cord blood processing system for laboratory use in conjunction with a specific and compatible single-use isolation kit provided by the original manufacturer. This product provides fast, automated, and reproducible separation of cord blood in a closed and sterile environment.

B Hematology, pathology, and genetics

B.9900 Cord blood processing systems and storage containers

QMS/QSD;; ่ผธๅ…ฅ

Dates and Status

Jun 08, 2023

Jun 08, 2028